Lime Therapeutics-preview

Limetx

Lime Therapeutics

Private

New York City, New YorkHealthcare & Life Scienceshttps://www.limetx.com

Last Round

Seed

Apr 8, 2024

Total Funding Raised

$100,000

Company Overview

Lime Therapeutics is a biopharmaceutical company that spun out of Memorial Sloan Kettering Cancer Center. The company is focused on developing novel therapies by targeting lipid metabolism to reverse the drivers of various diseases. It utilizes its proprietary, high-throughput screening platform, LipidSense™, to discover and develop drugs that modulate aberrant lipid metabolism in conditions such as cancer, cardiometabolic diseases, and neurodegenerative disorders. The company's initial therapeutic focus is on non-small cell lung cancer. Founded in 2021, Lime Therapeutics is venture-backed and based in New York City.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

lipid metabolismdrug discovery platformplatform biotechmetabolic oncologysmall molecule discoveryhigh-throughput screeningHTStarget identificationcancer therapeuticsliver cancerhepatocellular carcinomafirst-in-class medicinespharma partnershipscardiometabolic diseaseneurodegenerative diseasenon-small cell lung cancerNSCLCNAFLD/NASHatherosclerosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lime Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lime Therapeutics Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Apr 8, 2024
Grant	Mar 8, 2022

View all Funding Rounds

Lime Therapeutics Investors

Notable investors and investment history

Investor	Rounds
Coho Deeptech	Seed
LifeX Ventures	Seed
ZAKA VC	Seed

View all Investors

Lime Therapeutics Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Lime Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lime Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York

Year Founded2021

Last FundingApr 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.